April 2014 Archives

The markets closed higher with the Dow gaining 45 points to close at a record 16,580 after the Federal Reserve said that the nation's economy improved recently. Nasdaq rose 11 points to 4,114.

On the upside 

A district court ruled in favor of Avanir Pharmaceuticals (Nasdaq: AVNR) in its patent infringement suit against Par Pharmaceuticals and Impax Laboratories.

LogMeIn (Nasdaq: LOGM) reported higher first quarter earnings and revenue that beat analyst expectations prompting the company to lift its full year revenue outlook.

U. S. Silica Holdings (NYSE: SLCA) reported higher first quarter earnings and revenue that topped analyst estimates.

On the downside 

Lihua International (Nasdaq: LIWA) will investigate allegations that chairman and chief executive Zhu Jianhua diverted company assets.

First quarter earnings fell for Regional Management (NYSE: RM) even as revenue rose.

Cray (Nasdaq: CRAY) widened losses for the first quarter as revenue plunged.

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by more than 5 to 4 on Nasdaq. The broader S&P 500 rose 5 points to 1883. Bitcoin added $2.44 or 0.55% to $444.09.

The markets traded mixed during the midday with the Dow rising 11 points to 16,546 despite disappointingly weak economic growth as investors await the Federal Reserve's statement this afternoon. Nasdaq slipped 10 points to 4,093.

On the upside 

Aspen Technology (Nasdaq: AZPN) reported higher third quarter earnings and revenue that surpassed analyst expectations prompting an upgrade.

Level 3 Communications (NYSE: LVLT) reversed year ago losses to post a greater than expected profit for the first quarter as revenue rose.

FX Energy (Nasdaq: FXEN) reported a better than expected estimated production rate of 24 Mmcf/d for its Tuchola Field.

On the downside 

Vistaprint (Nasdaq: VPRT) disappointed with sharply lower third quarter earnings that fell far short of analyst expectations as revenue slipped prompting a downgrade.

Auxilium Pharmaceuticals (Nasdaq: AUXL) blamed lower than expected sales of its Testim testosterone gel for cutting its 2014 revenue and earnings outlook.

FEI (Nasdaq: FEIC) reported lower first quarter earnings that missed expectations and forecast current quarter earnings below estimates.

In the broad market, declining issues outpaced advancers by a margin of 5 to 3 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 held steady at 1878. Bitcoin edged up $0.56 or 0.13% to $442.22.

Anemic GDP Weighs Down Markets

|

Disappointingly weak economic growth of 0.1% in the first quarter weighed the markets down to a lower open with the Dow easing a point to 16,533. Nasdaq fell 23 points to 4,080.

On the upside 

Exelon will pay approximately $6.83 billion to acquire Pepco Holdings (NYSE: POM).

Energizer Holdings (NYSE: ENR) reported higher second quarter earnings and announced plans to separate into two publicly traded companies.

An independent investigation committee found no evidence of fraud by NQ Mobile (NYSE: NQ).

On the downside 

Twitter (NYSE: TWTR) widened first quarter losses and reported slower user growth than expected.

Power Integrations (Nasdaq: POWI) reported higher first quarter earnings and revenue but the results fell short of expectations.

DreamWorks (Nasdaq: DWA) fell to a greater than expected loss for the first quarter due to a significant charge from "Mr. Peabody."

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 lost 4 points to 1873. Bitcoin edged up $1.56 or 0.35% to $443.22.

Strong Earnings Lift Markets

|

The markets closed higher with the Dow gaining 86 points to 16,535 on upbeat earnings. Nasdaq climbed 29 points to 4,103.

On the upside 

The Wall Street Journal reported that Novavax's (Nasdaq: NVAX) Phase 2 trial of its respiratory ailment vaccine for women was successful.

Sprint (NYSE: S) narrowed losses more than expected as fewer subscribers switched to a competitor.

Luminex (Nasdaq: LMNX) reversed year ago losses to post a stronger than expected profit for the first quarter as revenue rose.

On the downside 

ABB (NYSE: ABB) reported lower first quarter earnings and revenue that fell short of analyst expectations.

Prothena (Nasdaq: PRTA) released its presentation poster for the XIV International Symposium on Amyloidosis.

Ballard Power Systems (Nasdaq: BLDP) narrowed first quarter losses but revenue missed expectations.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by 10 to 9 on Nasdaq. The broader S&P 500 gained 8 points to 1878. Bitcoin eased $1.23 or 0.28% to $439.73.

Markets Advance As Fed Meets

|

The markets advanced during the midday with the Dow climbing 84 points to 16,533 as the Federal Reserve convened its policy meeting. Nasdaq gained 27 points to 4,101.

On the upside 

MLV & Co. upgraded Xoma (Nasdaq: XOMA) from a Hold rating to a Buy rating.

Winthrop Realty Trust (NYSE: FUR) adopted a liquidation plan.

Orbital Sciences (NYSE: ORB) will merge with Alliant Techsystems (NYSE: ATK) in a deal valued at approximately $5 billion.

On the downside 

Oi SA (Nasdaq: OIBR) priced its secondary offering of 2,142 million common shares.

Ultra Clean Holdings (Nasdaq: UCTT) swung to a profit for the first quarter but the results fell short of analyst expectations and the company forecast current quarter earnings below expectations.

First quarter earnings slipped for 3D Systems (NYSE: DDD) even as revenue climbed.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 gained 8 points to 1877. Bitcoin added $3.64 or 0.82% to $444.60.

Earnings Boost Markets

|

The markets opened higher with the Dow gaining 56 points to 16,504 on upbeat earnings. Nasdaq rose 5 points to 4,079.

On the upside 

Amicus Therapeutics (Nasdaq: FOLD) reported positive results from a Phase 3 study of its Fabry monotherapy migalastat.

Banco Santander (NYSE: BSBR) reported better than expected earnings for the first quarter.

Amkor Technology (Nasdaq: AMKR) reported higher first quarter earnings and revenue that surpassed analyst expectations.

On the downside 

Shares of Gogo (Nasdaq: GOGO) tumbled after AT&T (NYSE: T) announced plans to launch 4G LTE Internet access on continental U. S. flights in 2015.

Shares of Plug Power (Nasdaq: PLUG) continued falling.

Coach (NYSE: COH) disappointed with sharply lower third quarter earnings as revenue fell.

In the broad market, advancing issues outpaced decliners by a margin of 2 to 1 on the NYSE and by 3 to 2 on Nasdaq. The broader S&P 500 rose 5 points to 1875. Bitcoin added $4.66 or 1.05% to $445.65.

Higher Close On Merger News

|

It was a higher close for the markets with the Dow gaining 87 points to 16,448 as investors shrugged off international concerns to embrace corporate consolidations. Nasdaq eased a point to 4,074.

On the upside 

Charter Communications (Nasdaq: CHTR) will gain 1.4 million customers from Comcast (Nasdaq: CMCSA) as part of an agreement to alleviate regulatory concerns about the merger of Comcast with Time Warner Cable (NYSE: TWC).

Agenus (Nasdaq: AGEN) entered a collaboration and license agreement with Merck (NYSE: MRK) to develop antibody based cancer immunotherapies.

Reuters reported that Allergan (NYSE: AGN) was in the process of making another offer for Shire (NYSE: SHPG).

On the downside 

Credit Suisse trimmed its solar installation demand outlook for 2014 which sent shares of JA Solar (Nasdaq: JASO) tumbling.

Investors locked in profits on ChannelAdvisor (NYSE: ECOM).

The Wall Street Journal reported that Och-Ziff Capital Management (NYSE: OZM) financed oil and mining deals in the Democratic Republic of Congo.

In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 gained 6 points to 1869. Bitcoin eased $1.11 or 0.25% to $440.31.

The markets traded mixed during the midday with the Dow climbing 64 points to 16,425 while Nasdaq fell 24 points to 4,050 as additional sanctions against Russia were announced.

On the upside 

American Realty Capital Properties (Nasdaq: ARCP) engaged in discussions to acquire NorthStar Realty Finance (NYSE: NRF).

Susser Holdings (NYSE: SUSS) will be acquired by Energy Transfer Partners (NYSE: ETP) in a deal valued at approximately $1.8 billion.

PVH (NYSE: PVH) said that its men's apparel brands are performing very well at J.C. Penney (NYSE: JCP).

On the downside 

Shares of Plug Power (Nasdaq: PLUG) extended its losses.

Shares of Canadian Solar (Nasdaq: CSIQ) and Trina Solar (NYSE: TSL) fell after Credit Suisse lower its 2014 solar installations demand forecast in China.

The Food and Drug Administration issued a complete response letter to Pozen (Nasdaq: POZN) for its PA8140/PA32540 delayed release tablets.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 added a point to 1865. Bitcoin eased $2.58 or 0.59% to $438.84.

Merger and acquisition news boosted the markets to a sharply higher open with the Dow surging 137 points to 16,498. Nasdaq climbed 30 points to 4,105.

On the upside 

Pfizer (NYSE: PFE) offered approximately $100 billion to acquire AstraZeneca (NYSE: AZN) over the weekend.

The Department of Defense will fund a new clinical trial for Galena Biopharma's (Nasdaq: GALE) breast cancer recurrence prevention treatment NeuVax.

Forest Laboratories (NYSE: FRX) will pay approximately $1.46 billion in cash and stock to purchase Furiex Pharmaceuticals (Nasdaq: FURX).

On the downside 

Athersys (Nasdaq: ATHX) reported disappointing results from a mid-stage clinical trial of its refractory ulcerative colitis treatment MultiStem cell therapy.

OncoGenex Pharmaceuticals (Nasdaq: OGXI) reported that its prostate cancer treatment custirsen failed a late-stage clinical trial.

New Oriental Education and Technology Group (NYSE: EDU) reported higher third quarter earnings and revenue but the number of schools and learning centers fell.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 climbed 13 points to 1876. Bitcoin slipped $6.62 or 1.52% to $434.80.

The markets tumbled to close sharply lower with the Dow plummeting 140 points to 16,361 as earnings disappointed. Nasdaq collapsed 72 points to 4,075.

On the upside 

Prestige Brands Holdings (NYSE: PBH) will pay approximately $750 million to acquire Insight Pharmaceuticals.

Itron (Nasdaq: ITRI) reported a loss for the first quarter but the results were better than expected as revenue rose.

First quarter earnings slipped for Echo Global Logistics (Nasdaq: ECHO) but the results beat expectations and the company forecast full year revenue ahead of estimates.

On the downside 

Freescale Semiconductor (NYSE: FSL) narrowed first quarter losses more than expected but the stock price dropped.

Mellanox Technologies (Nasdaq: MLNX) disappointed by widening first quarter losses more than expected.

Plug Power (Nasdaq: PLUG) priced its public offering of 22.6 million common shares at the discounted price of $5.50 per share.

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by more than 5 to 1 on Nasdaq. The broader S&P 500 tumbled 15 points to 1863. Bitcoin fell $34.66 or 7.58% to $457.00.

Markets Extend Losses At Midday

|

The markets extended its losses during the midday with the Dow plunging 108 points to 16,393. Nasdaq plummeted 52 points to 4,096.

On the upside 

Third quarter earnings slipped for DeVry Education Group (NYSE: DV) but the results beat expectations.

Healthways (Nasdaq: HWAY) reported a smaller than expected loss for the first quarter as revenue rose.

Newpark Resources (NYSE: NR) reported sharply higher first earnings.

On the downside 

Pandora (NYSE: P) narrowed losses for the first quarter but the Internet radio service provider forecast current quarter results that fell short of analyst expectations.

Fourth quarter earnings slipped for CommVault Systems (Nasdaq: CVLT) as revenue fell short of expectations.

CalAmp (Nasdaq: CAMP) disappointed with sharply lower fourth quarter earnings that missed analyst estimates and forecast current quarter results below expectations.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 dropped 12 points to 1866. Bitcoin fell $40.41 or 8.96% to $451.25.

Disappointing earnings sent the markets tumbling to a sharply lower open with the Dow plummeting 102 points to 16,399. Nasdaq plunged 45 points to 4,103.

On the upside 

Weatherford International (NYSE: WFT) fell to a loss for the first quarter but the results were better than expected.

Lattice Semiconductor (Nasdaq: LSCC) reported higher first quarter earnings and revenue that topped analyst expectations and forecast current quarter revenue ahead of estimates.

Synaptics (Nasdaq: SYNA) fell to a loss for the third quarter but the results beat analyst expectations prompting an upgrade.

On the downside 

Cytokinetics (Nasdaq: CYTK) reported disappointing results from a mid-stage clinical trial of its Lou Gehrig's disease treatment tirasemtiv.

Yingli Green Energy (NYSE: YGE) priced its follow-on public offering of 25 million American Depositary Shares at the discounted price of $3.50 per ADS.

Concerns of more government regulation in Russia sent shares of Yandex (Nasdaq: YNDX) tumbling.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 1869. Bitcoin dropped $43.09 or 9.61% to $448.57.

The markets ended the day mixed with the Dow closing flat at 16,501 while the tech heavy Nasdaq gained 21 points to 4,148 on strong earnings from Apple.

On the upside 

Reuters reported that Elizabeth Arden (Nasdaq: RDEN) retained the services of Goldman Sachs to explore a potential sale of the cosmetics company.

VASCO Data Security International (Nasdaq: VDSI) reported higher first quarter earnings and revenue.

Ultratech (Nasdaq: UTEK) fell to a loss for the first quarter but the company expects a stronger second half of the year.

On the downside 

Parametric Sound (Nasdaq: HEAR) priced its public offering of 4 million common shares at the discounted price of $10.00 per share.

Clearfield (Nasdaq: CLFD) reported sharply higher second quarter earnings and revenue but the results fell short of analyst expectations.

Tsakos Energy Navigation (NYSE: TNP) priced its public offering of 11 million common shares at the discounted price of $7.30 per share.

In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners outpaced advancers by 7 to 5 on Nasdaq. The broader S&P 500 added 3 points to 1878. Bitcoin rose $4.29 or 0.88% to $489.95.

Markets Advance At Midday

|

The markets advanced during the midday with the Dow rising 15 points to 16,517. Nasdaq gained 27 points to 4,154.

On the upside 

First quarter earnings slipped for Citrix Systems (Nasdaq: CTXS) but the results were better than expected and the company increased its stock repurchase program by $1.5 billion.

Maxim Group initiated coverage of Cesca Therapeutics (Nasdaq: KOOL) with a Buy rating.

D.R. Horton (NYSE: DHI) reported higher second quarter earnings and revenue that topped analyst expectations.

On the downside 

Fusion-io (NYSE: FIO) widened losses for the third quarter even as revenue rose.

First quarter earnings plunged for Ingram Micro (NYSE: IM) to fall short of analyst expectations.

Eagle Rock Energy Partners (Nasdaq: EROC) suspended its quarterly cash distribution prompting Bank of America to lower its price target on the company from $6.50 to $5.50.

In the broad market, advancing issues outpaced decliners by a margin of 9 to 7 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 rose 5 points to 1881. Bitcoin slipped $1.48 or 0.31% to $484.18.

Upbeat earnings lifted the markets to a higher open with the Dow adding a point to 16,503 Nasdaq rose 12 points to 4,139.

On the upside 

Zimmer Holdings (NYSE: ZMH) will pay approximately $13.35 billion in cash and stock to acquire Biomet.

Apple (Nasdaq: AAPL) reported higher second quarter earnings that topped analyst estimates, increased its stock repurchase program and announced a 7-for-1 stock split.

Third quarter earnings surged for Lam Research (Nasdaq: LRCX) to beat analyst expectations and the company forecast current quarter earnings ahead of estimates.

On the downside 

Xilinx (Nasdaq: XLNX) reported higher fourth quarter earnings but the results missed expectations.

First quarter earnings surged for Under Armour (NYSE: UA) to top analyst estimates but the stock price fell.

ServiceNow (NYSE: NOW) widened first quarter losses even as revenue surged.

In the broad market, declining issues outpaced advancers by a margin of nearly 9 to 7 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 edged up a point to 1876. Bitcoin eased $0.66 or 0.14% to $485.00.

Plunging new home sales weighed the markets down to a lower close with the Dow slipping 12 points to 16,501. Nasdaq tumbled 34 points to 4,126.

On the upside 

Second quarter earnings slipped for Sanmina (Nasdaq: SANM) but the results were better than expected and the company forecast current quarter earnings ahead of estimates.

The final arbitration ruling in Hugoton Royalty Trust's (NYSE: HGT) proceedings against XTO Energy favored Hugoton Royalty Trust.

South Korean cosmetics company LG Household may explore purchasing Elizabeth Arden (Nasdaq: RDEN).

On the downside 

Unisys (NYSE: UIS) widened first quarter losses as revenue slipped.

Noranda Aluminum (NYSE: NOR) fell to a greater than expected loss for the first quarter as revenue dropped.

Zix (Nasdaq: ZIXI) reported higher first quarter earnings and revenue but the company forecast current quarter results below expectations.

In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 slipped 4 points to 1875. Bitcoin edged up $0.17 or 0.04% to $483.30.

The markets traded lower during the midday with the Dow losing 10 points to 16,503 as new home sales plummeted in March. Nasdaq fell 24 points to 4,136.

On the upside 

Israeli business newspaper Globes reported that Starbucks (Nasdaq: SBUX) engaged in discussions to acquire a 10% stake in SodaStream International (Nasdaq: SODA).

Shares of GW Pharmaceuticals (Nasdaq: GWPH) continued rising after Morgan Stanley set a $103 price target on the medical marijuana company yesterday.

Xoom (Nasdaq: XOOM) reversed year ago losses to post a stronger than expected profit for the first quarter as revenue surged.

On the downside 

Zhone Technologies (Nasdaq: ZHNE) disappointed with flat first quarter earnings and revenue.

First quarter earnings tumbled for iRobot (Nasdaq: IRBT).

Intuitive Surgical (Nasdaq: ISRG) reported sharply lower first quarter earnings and revenue.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners edged out advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 eased a point to 1878. Bitcoin slipped $1.66 or 0.34% to $481.48.

New home sales plunged in March to weigh the markets down to a lower open with the Dow slipping 11 points to 16,502. Nasdaq lost 21 points to 4,139.

On the upside 

Skyworks Solutions (Nasdaq: SWKS) reported higher second quarter earnings and revenue that topped analyst estimates and forecast current quarter results ahead of expectations.

Supervalu (NYSE: SVU) swung to a stronger than expected profit for the fourth quarter as revenue rose.

Cognex (Nasdaq: CGNX) received two purchase orders valued at more than $40 million.

On the downside 

Cree (Nasdaq: CREE) reported higher third quarter earnings and revenue but gross margin slipped.

Third quarter earnings and revenue rose for VMware (NYSE: VMW) but a number of enterprise license agreements were delayed.

International Game Technology (NYSE: IGT) reported sharply lower second quarter earnings as revenue fell.

In the broad market, advancing issues were on par with decliners on the NYSE while decliners outpaced advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 eased a point to 1877. Bitcoin slipped $1.70 or 0.35% to $481.44.

Merger news along with strong earnings lifted the markets to a higher
close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points
to 4,161.
 
On the upside
 
Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside


A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.
Merger news along with strong earnings lifted the markets to a higher
close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points
to 4,161.
 
On the upside
 
Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside


A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Strong Earnings Boost Markets

|

Strong corporate earnings boosted the markets during the midday with the Dow soaring 114 points to 16,563. Nasdaq surged 46 points to 4,168.

On the upside 

Morgan Stanley initiated coverage of GW Pharmaceuticals (Nasdaq: GWPH) with an Overweight rating and a price target of $103.

First quarter earnings dropped for Rent-A-Center (Nasdaq: RCII) but the results were better than expected and the company forecast full year earnings ahead of estimates.

Robert W. Baird lifted its price target on Sarepta Therapeutics (Nasdaq: SRPT) from $35 to $55.

On the downside 

A Seeking Alpha article said that Arotech (Nasdaq: ARTX) was worth only $2 per share.

First quarter earnings soared for Pentair (NYSE: PNR) but revenue fell to miss analyst expectations.

RadioShack (NYSE: RSH) executive vice president of store operations Troy Risch resigned.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 climbed 12 points to 1884. Bitcoin eased $0.60 or 0.12% to $487.90.

Upbeat Earnings Lift Markets

|

Upbeat earnings lifted the markets to a higher open with the Dow climbing 66 points to 16,516. Nasdaq gained 31 points to 4,153.

On the upside 

Valeant Pharmaceuticals (NYSE: VRX) offered a premium of approximately $46 billion in cash and stock to acquire Allergan (NYSE: AGN).

Netflix (Nasdaq: NFLX) reported sharply higher first quarter earnings that topped analyst estimates and announced price increases for new customers.

First quarter earnings and revenue rose for Centene (NYSE: CNC) to beat analyst expectations.

On the downside 

Arch Coal (NYSE: ACI) widened first quarter losses more than expected prompting the company to cut its shipment forecast.

Medidata Solutions (Nasdaq: MDSO) fell to a loss for the first quarter.

First quarter earnings and revenue fell for Lexmark (NYSE: LXK)

In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by a margin of more than 5 to 3 on Nasdaq. The broader S&P 500 climbed 7 points to 1879. Bitcoin edged up $1.70 or 0.35% to $490.21.

Higher Close On Light Trading

|

The markets closed higher on a light trading day with the Dow gaining 40 points to 16,449. Nasdaq climbed 26 points to 4,121.

On the upside 

Tarena International (Nasdaq: TEDU) partnered with Bank of China Consumer Financed partnered to provide student loans to Tarena students.

Piper Jaffray mentioned Cytokinetics (Nasdaq: CYTK) positively.

Regado Biosciences (Nasdaq: RGDO) beneficial owner Robert A Kierlin purchased 575,000 shares of company stock.

On the downside 

Plug Power (Nasdaq: PLUG) will create a joint venture with Hyundai Hysco to develop and market hydrogen fuel cells in Asia.

Hedgeye analyst Kevin Kaiser said that there was considerable downside to Atlas Energy (NYSE: ATLS).

Athenahealth (Nasdaq: ATHN) fell to a greater than expected loss for the first quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by a margin of more than 7 to 5 on Nasdaq. The broader S&P 500 gained 7 points to 1871. Bitcoin edged up $0.07 or 0.02% to $489.82.

Markets Advance At Midday

|

The markets advanced during the midday with the Dow rising 35 points to 16,444 as investors continued to monitor earnings. Nasdaq gained 17 points to 4,113.

On the upside 

Aastrom Biosciences (Nasdaq: ASTM) will pay approximately $6.5 million to acquire Sanofi's Cell Therapy and Regenerative Medicine business.

Shares of Weibo (Nasdaq: WB) continued rising after a strong debut last week.

First quarter earnings slipped for Select Comfort (NYSE: SCSS) but revenue rose to top estimates.

On the downside 

Acacia Research (Nasdaq: ACTG) fell to a greater than expected loss for the first quarter as revenue plunged.

Sterne Agee analyst Sam Poser said that Lululemon Athletica (Nasdaq: LULU) needed a plan to improve sales.

Cepheid (Nasdaq: CPHD) fell to a loss for the first quarter even as revenue rose and cut its full year earnings guidance.

In the broad market, advancing issues outpaced decliners by a margin of 4 to 3 on the NYSE and by a margin of more than 7 to 5 on Nasdaq. The broader S&P 500 rose 4 points to 1869. Bitcoin eased $1.71 or 0.35% to $488.04.

Higher Open Over Earnings

|

The markets opened higher with the Dow rising 32 points to 16,441 on upbeat earnings. Nasdaq added 4 points to 4,100.

On the upside 

Sarepta Therapeutics (Nasdaq: SRPT) will submit a New Drug Application for its Duchenne Muscular Dystrophy treatment eteplirsen by the end of 2014.

Birch Communications will pay a premium of approximately $323 million in cash to acquire Cbeyond (Nasdaq: CBEY).

Shares of Advanced Micro Devices (NYSE: AMD) rose after reporting better than expected results last week.

On the downside

Goldman Sachs downgraded Walter Energy (NYSE: WLT) from a Neutral rating to a Sell rating and slashed its price target from $9 to $5.

Shares of Moneygram International (Nasdaq: MGI) continued falling after Wal-Mart's announced its entry into the money transfer service business last week.

Merger discussions between Barrick Gold (NYSE: ABX) and Newmont Mining (NYSE: NEM) have ended.

In the broad market, advancing issues outpaced decliners by a margin of nearly 9 to 7 on the NYSE and by a margin of nearly 5 to 4 on Nasdaq. The broader S&P 500 added 2 points to 1867. Bitcoin rose $5.65 or 1.14% to $495.40.

U. S. Markets Closed

|
U. S. markets are closed for Good Friday.

It was a mixed close for the markets with the Dow losing 16 points to 16,408 as earnings disappointed but first time applications for jobless claims rose less than expected. Nasdaq rose 9 points to 4,095.

On the upside 

Shares of Weibo (Nasdaq: WB) soared in its market debut.

Leju Holdings (NYSE: LEJU) stock surged on its first trading day.

Zynga (Nasdaq: ZNGA) introduced its new mobile game FarmVille 2: Country Escape.

On the downside

Investors locked in profits on Zalicus (Nasdaq: ZLCS).

Chipotle Mexican Grill (NYSE: CMG) reported higher first quarter earnings but the results fell short of analyst expectations as expenses rose and the fast casual Mexican restaurant chain announced its first price increase in three years.

First quarter earnings rose for Alliance Data Systems (NYSE: ADS) but revenue fell short of analyst expectations and the company forecast current quarter earnings below analyst estimates.

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on the NYSE and by a margin of more than 5 to 3 on Nasdaq. The broader S&P 500 rose 2 points to 1864. Bitcoin lost $33.41 or 6.66% to $494.24.

Mixed Markets At Midday

|

The markets traded mixed during the midday with the Dow slipping 12 points to 16,412 as jobless claims rose less than expected. Nasdaq added 5 points to 4,091.

On the upside 

Bargain hunters snapped up shares of LiveDeal (Nasdaq: LIVE).

Morgan Stanley (NYSE: MS) impressed with sharply higher first quarter earnings that beat expectations as revenue climbed.

General Electric (NYSE: GE) reported lower first quarter earnings but the results topped analyst estimates.

On the downside

Chemtura (NYSE: CHMT) will sell its AgroSolutions agrichemicals business to competitor Platform Specialty Products for approximately $1 billion in cash and stock.

Plans by RadioShack (NYSE: RSH) to close up to 1,100 stores have been opposed by its lenders.

Renewable Energy Group (Nasdaq: REGI) warned of losses for the first quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE and by a margin of more than 5 to 3 on Nasdaq. The broader S&P 500 added a point to 1863. Bitcoin fell $34.17 or 6.48% to $492.99.

Mixed Open Over Earnings

|

The markets opened mixed with the Dow slipping 28 points to 16,396 while Nasdaq rose 10 points to 4,096 as investors continued to monitor corporate earnings.

On the upside 

First quarter earnings soared for SanDisk (Nasdaq: SNDK) to surpass analyst expectations prompting Credit Suisse and Jefferies to raise their price targets on the flash memory maker.

JPMorgan upgraded Boardwalk Pipeline Partners (NYSE: BWP) from an Underweight rating to an Overweight rating.

Shares of Sabre (Nasdaq: SABR) rose on its first trading day.

On the downside

Barnes & Noble (NYSE: BKS) founder and chairman Leonard Riggio reduced his stake in the company from 26.3% to approximately 20% by selling 3.7 million shares.

Shares of Moneygram International (Nasdaq: MGI) and Western Union (NYSE: WU) fell on Wal-Mart's (NYSE: WMT) announcement that it would begin offering a domestic money transfer service on April 24.

The Constitutional Court of South Africa ruled that a contract awarded to Net 1 UEPS Technologies (Nasdaq: UEPS) was invalid and a new tender process must be initiated.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by a margin of nearly 5 to 3 on Nasdaq. The broader S&P 500 lost 3 points to 1859. Bitcoin fell $32.52 or 6.17% to $494.63.

Markets Soar On Upbeat Data

|

The markets soared to close sharply higher with the Dow surging 162 points to 16,424 on upbeat economic data along with assurances from Federal Reserve chair Janet Yellen that interest rates would remain low. Nasdaq climbed 52 points to 4,086.

On the upside 

Shares of TriVascular Technologies (Nasdaq: TRIV) climbed in its market debut.

Apricus Biosciences (Nasdaq: APRI) United Kingdom partner Takeda Pharmaceuticals accepted its first shipment of the topical erectile dysfunction treatment Vitaros.

Credit Suisse initiated coverage of Bitauto Holdings (NYSE: BITA)  with a Buy rating and a $46 price target.

On the downside

Adtran (Nasdaq: ADTN) reported higher first quarter earnings but revenue fell short of expectations.

Shares of RadioShack (NYSE: RSH) continued falling after a competitor cut its outlook yesterday.

Brinker Capital implemented the social platform solution Proofpoint Archiver for Chatter (Nasdaq: PFPT) but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of nearly 4 to 1 on the NYSE and by a margin of nearly 5 to 2 on Nasdaq. The broader S&P 500 soared 19 points to 1862. Bitcoin edged up $2.22 or 0.44% to $508.22.

A stronger than expected 0.7% gain in March industrial production boosted the markets during the midday with the Dow surging 125 points to 16,388. Nasdaq climbed 39 points to 4,073.

On the upside 

Calcalist reported that SodaStream International (Nasdaq: SODA) engaged in discussions to sell up to a 16% stake in the company.

Goldman Sachs upgraded SouFun Holdings (NYSE: SFUN) from a Neutral rating to a Buy rating.

Shares of Weatherford (NYSE: WFT) rose as oil rig counts continued climbing.

On the downside

Bank of America (NYSE: BAC) blamed significant legal expenses for falling to a loss for the first quarter.

Agnico Eagle Mines (NYSE: AEM) and Yamana Gold (NYSE: AUY) will jointly acquire Osisko Mining.

First quarter earnings fell for CSX (NYSE: CSX) and the railroad company warned that severe winter weather would continue to negatively impact current quarter earnings.

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by a margin of nearly 5 to 2 on Nasdaq. The broader S&P 500 rose 9 points to 1852. Bitcoin added $4.10 or 0.81% to $510.10.

The Chinese economy expanded at a greater than expected pace of 7.4% in the first quarter to lift the markets to a sharply higher open with the Dow soaring 98 points to 16,360. Nasdaq gained 28 points to 4,062.

On the upside 

Zalicus (Nasdaq: ZLCS) will merge with Epirus Biopharmaceuticals.

A district court issued an injunction prohibiting Massachusetts from banning the sale of Zogenix's (Nasdaq: ZGNX) pain medication Zohydro.

Yahoo (Nasdaq: YHOO) reported lower first quarter earnings but the results topped analyst estimates.

On the downside

xG Technology (Nasdaq: XGTI) priced its public offering of 5.265 million common shares at the discounted price of $1.90 per share.

Linear Technology (Nasdaq: LLTC) reported higher third quarter earnings and revenue but revenue fell short of expectations.

First quarter earnings soared for ASML Holdings (Nasdaq: ASML) but the company warned of slowing revenue in the current quarter and lowered its sales guidance for the first half of the year.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 1 on the NYSE and by a margin of nearly 7 to 2 on Nasdaq. The broader S&P 500 rose 9 points to 1852. Bitcoin edged up $1.29 or 0.26% to $507.29.

Markets Recover In Late Afternoon

|

The markets recovered in late afternoon trading to close higher with the Dow climbing 89 points to 16,262. Nasdaq rose 11 points to 4,034.

On the upside 

NQ Mobile (NYSE: NQ) repurchased its stock in the aftermath of a sharp drop due to disappointing results.

Twitter (NYSE: TWTR) paid an undisclosed sum for data partner Gnip.

Splunk (Nasdaq: SPLK) introduced the Splunk App for VMware.

On the downside

Comverse (Nasdaq: CNSI) reported lower fourth quarter revenue that fell short of analyst expectations.

Arrowhead Research (Nasdaq: ARWR) extended its losses.

Zebra Technologies (Nasdaq: ZBRA) will fund its $3.45 billion cash acquisition of Motorola Solutions' enterprise business through new debt.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE while decliners edged out advancers by a slim margin of 10 to 9 on Nasdaq. The broader S&P 500 gained 12 points to 1842. Bitcoin rose $10.00 or 1.98% to $516.00.

Sell-Off Resumes

|

The sell-off resumed in earnest with the Dow losing 93 points to 16,079 while the tech-heavy Nasdaq tumbled 67 points to 3,954.

On the upside 

Two 10% beneficial owners of Conn's (Nasdaq: CONN) purchased shares of company stock.

Coca-Cola (NYSE: KO) reported lower first quarter earnings and revenue but revenue topped analyst estimates.

Sears Holdings (Nasdaq: SHLD) appointed Arun Arora to the position of senior vice president and president of Home Services.

On the downside

Gevo (Nasdaq: GEVO) reported a loss for the year.

Brink's (NYSE: BCO) warned of a significant write down in the first quarter due to a change from Venezuela's official exchange rate to the SICAD II floating rate.

Pep Boys (NYSE: PBY) reported an unexpected loss for the fourth quarter as revenue fell.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 lost 11 points to 1818. Bitcoin gained $44.36 or 9.73% to $500.45.

The markets opened mixed with the Dow adding 3 points to 16,177 while Nasdaq fell 17 points to 4004 as consumer prices rose more than expected in March. 

On the upside 

Micron Technology (Nasdaq: MU) and Wave Systems (Nasdaq: WAVX) expanded their partnership to improve protection against emerging threats to connected devices.

Highpower International (Nasdaq: HPJ) will supply Sony with battery products.

FX Energy (Nasdaq: FXEN) reported sample core data that exceeded its expectations at the Tuchola-4K well and will run a drill stem test of the additional 70 meter open interval that was drilled.

On the downside

Dilutions concerns weighed down shares of National Bank of Greece (NYSE: NBG).

Aaron's (NYSE: AAN) will pay approximately $700 million in cash to acquire Progressive Finance Holdings and has rejected a $30.50 per share acquisition offer from Vintage Capital Management.

Infosys (NYSE: INFY) reported higher fourth quarter earnings but revenue fell short of expectations.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 added a point to 1831. Bitcoin gained $35.90 or 7.87% to $492.00.

The markets surged to close sharply higher with the Dow jumping 146 points to 16,173 as March retail sales climbed more than expected. Nasdaq gained 22 points to 4022. 

On the upside 

UBS initiated coverage of Akebia Therapeutics (Nasdaq: AKBA) with a Buy rating.

Janney Capital upgraded Bebe Stores (Nasdaq: BEBE) from a Neutral rating to a Buy rating.

Shares of Cash America International (NYSE: CSH) continued rising.

On the downside

SMTC (Nasdaq: SMTX) fell to a loss for the fourth quarter.

Retrophin (Nasdaq: RTRX) raised its revenue forecast for 2014 and 2015 but reported that the Food and Drug Administration refused to grant a clinical trial for RE-024 as an Investigational New Drug.

Northwest Biotherapeutics (Nasdaq: NWBO) entered an agreement to sell more than 2.27 million common shares at $6.60 to an institutional investor.

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 climbed 14 points to 1829. Bitcoin soared $52.56 or 12.98% to $457.32.

The markets continued to advance during the midday with the Dow leaping 123 points to 16,150 on strong March retail sales. Nasdaq climbed 29 points to 4029. 

On the upside 

Endurance Specialty Holdings offered a premium of approximately $3.2 billion to acquire Aspen Insurance (NYSE: AHL).

The Wall Street Transcript interviewed Stillwater Mining (NYSE: SWC) chief executive Mick McMullen.

JA Solar Holdings (Nasdaq: JASO) expects first quarter shipments to surpass its previous forecast.

On the downside

Shares of NQ Mobile (NYSE: NQ) extended its losses.

Ericsson (Nasdaq: ERIC) announced the resignation of Senior Vice President and Head of Group Function Strategy Douglas Gilstrap effective August 1, 2014.

Shares of Eagle Bulk Shipping (Nasdaq: EGL) continued falling.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 climbed 13 points to 1828. Bitcoin soared $59.02 or 14.58% to $463.80.

March retail sales increased more than expected to lift the markets to a higher open with the Dow climbing 80 points to 16,106. Nasdaq gained 17 points to 4016. 

On the upside 

Goodrich Petroleum (NYSE: GDP) completed its Blades 33H-1 well in Tangipahoa Parish, Louisiana with a peak production rate to 1,270 barrels of oil equivalent per day.

A federal court ordered a preliminary injunction that limits sales of Medtronic's (NYSE: MDT) CoreValve system because CoreValve willfully infringed on an Edwards Lifesciences (NYSE: EW) patent.

WebMD Health (Nasdaq: WBMD) expects first quarter earnings to top its previous forecast.

On the downside

Reuters reported that Goldman Sachs and Morgan Stanley would coordinate the equity offering of National Bank of Greece (NYSE: NBG) to cover a 2.18 billion euro capital shortfall.

Antero Resources (NYSE: AR) provided an operations update for the first quarter.

Highpower International (Nasdaq: HPJ) announced a registered direct offering of 1 million common shares at the discounted price of $5.05 per share to several institutional investors.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 gained 9 points to 1824. Bitcoin climbed $43.32 or 10.70% to $448.10.

Weak earnings sent the markets tumbling to a sharply lower close with the Dow plunging 143 points to 16,026. Nasdaq plummeted 54 points to 3999. 

On the upside 

Shares of Zoe's Kitchen (NYSE: ZOES) leaped on its first trading day.

Enable Midstream Partners (NYSE: ENBL) stock soared in its market debut.

BMO Capital Markets upgraded JAKKS Pacific (Nasdaq: JAKK) from a Market Perform rating to an Outperform rating.

On the downside

Financial Times reported that the Federal Bureau of Investigation and the Department of Justice have been investigating Herbalife (NYSE: HLF) for possible criminal activity.

JPMorgan Chase (NYSE: JPM) disappointed with lower first quarter earnings and revenue that fell short of analyst expectations.

Documents that were released this afternoon indicated that current General Motors (NYSE: GM) chief executive Mary Barra was informed about safety concerns in 2011 about the Saturn Ion and Chevrolet Cobalt.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 tumbled 17 points to 1815. Bitcoin climbed $47.86 or 12.87% to $419.64.

The markets traded lower during the midday with the Dow falling 80 points to 16,090 as corporate earnings disappointed. Nasdaq lost 20 points to 4033. 

On the upside 

Shares of Phibro Animal Health (Nasdaq: PAHC) climbed in its market debut.

Zacks Equity Research noted that Thompson Creek Metals (NYSE: TC) had potential to continue climbing.

Diamondback Energy (Nasdaq: FANG) reported a 30% increase in first quarter production prompting Mizhuo Financial to lift its price target from $74 to $80.

On the downside

Wall St. Cheat Sheet recommended that investors sell J.C. Penney (NYSE: JCP) stock.

Datawatch (Nasdaq: DWCH) warned of losses for the second quarter.

TTM Technologies (Nasdaq: TTMI) updated its first quarter revenue guidance to the low end of its previous forecast.

In the broad market, declining issues outpaced advancers by a margin of 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 lost 7 points to 1825. Bitcoin climbed $44.04 or 11.86% to $415.42.

Disappointing results from JP Morgan weighed the markets down to a lower open with the Dow tumbling 94 points to 16,075. Nasdaq dropped 27 points to 4026. 

On the upside 

Ametek will pay a premium of $19.25 per share in cash to acquire Zygo (Nasdaq: ZIGO).

Jefferies analyst Mark Wiltamuth increased his price target on Rite Aid (NYSE: RAD) from $5.30 to $7.50.

Standard & Poor's Ratings Services and Moody's Investors Service both upgraded the ratings on SiriusXM's (Nasdaq: SIRI) 5.25% Senior Notes due 2011 to investment grade.

On the downside

Regado Biosciences (Nasdaq: RGDO) priced its public offering of 10 million common shares at the discounted price of $6 per share.

Voxeljet (NYSE: VJET) priced its public offering of 3 million American Depositary Shares at the discounted price of $15 per ADS.

NQ Mobile (NYSE: NQ) fell to a greater than expected loss for the fourth quarter.

In the broad market, declining issues outpaced advancers by a margin of 5 to 2 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 fell 8 points to 1824. Bitcoin climbed $40.62 or 10.94% to $412.00.

The markets plunged to close sharply lower with the Dow collapsing 266 points to 16,170 despite a drop in jobless claims as investors locked in profits. Nasdaq plummeted 129 points to 4054. 

On the upside 

Ruby Tuesday (NYSE: RT) reported a loss for the third quarter but the results were better than expected.

First quarter earnings slipped for iGate (Nasdaq: IGTE) but the results were better than expected as revenue rose.

Titan Machinery (Nasdaq: TITN) fell to a loss for the fourth quarter but the results beat analyst expectations.

On the downside

Motley Fool warned investors against buying FireEye (Nasdaq: FEYE).

Shares of Adamas Pharmaceuticals (Nasdaq: ADMS) tumbled on its first trading day.

Motley Fool wrote that start-up Form Labs was selling high-end 3-D printers for a fraction of the cost that 3D Systems (NYSE: DDD) was charging.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by nearly 7 to 1 on Nasdaq. The broader S&P 500 plummeted 39 points to 1833. Bitcoin dropped $57.84 or 13.18% to $380.95.

The markets opened mixed with the Dow rising 4 points to 16,441 even as jobless claims dropped to a seven year low. Nasdaq tumbled 34 points to 4149. 

On the upside 

Fourth quarter earnings for Rite Aid (NYSE: RAD) beat analyst expectations as revenue rose.

GSO Capital partners invested $150 million in Rentech (Nasdaq: RTK). Rentech also reached a settlement agreement with Concerned Rentech Shareholders.

The Food and Drug Administration granted 510(k) clearance to Baxano Surgical (Nasdaq: BAXS) for its Avance MIS Pedicle Screw System.

On the downside

Imperva (NYSE: IMPV) warned that first quarter earnings and revenue would fall short of previous guidance prompting a downgrade.

Bed Bath & Beyond (Nasdaq: BBBY) disappointed with lower fourth quarter earnings and revenue and cut its first quarter outlook.

Box Ships (NYSE: TEU) priced its public offering of 5 million units at the discounted price of $2.05 per unit.

In the broad market, advancing issues were on par with decliners on the NYSE while decliners outpaced advancers by a margin of more than 5 to 2 on Nasdaq. The broader S&P 500 slipped 5 points to 1866. Bitcoin fell $27.86 or 6.35% to $410.94.

Markets Soar On Supportive Fed

|

Indications that the Federal Reserve would continue to support the economy sent the markets soaring to a sharply higher close with the Dow leaping 181 points to 16,437. Nasdaq jumped 70 points to 4183. 

On the upside 

Zacks Equity Research said that E-Commerce China Dangdang (Nasdaq: DANG) would likely beat earnings expectations.

Pacira Pharmaceuticals (Nasdaq: PCRX) priced its pubic offering of 1.6 million common shares at $64 per share.

Zacks Equity Research noted that TeleCommunication Systems' (Nasdaq: TSYS) stock price climbed recently.

On the downside

Morgan Stanley analyst Adam Jonas downgraded General Motors (NYSE: GM) from an Overweight rating to an Underweight rating, cut his earnings estimate and slashed the price target from $49 to $33.

Rising inflation in Brazil weighed down shares of Centrais El (NYSE: EBR).

Investors locked in profits on Prana Biotechnology (Nasdaq: PRAN).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 soared 20 points to 1872. Bitcoin slipped $7.29 or 1.63% to $440.21.

The markets advanced during the midday with the Dow climbing 79 points to 16,335 ahead of the release of minutes from the Federal Reserve's March meeting. Nasdaq soared 39 points to 4152. 

On the upside 

Shares of iKang Healthcare Group (Nasdaq: KANG) climbed in its market debut.

Wells Fargo upgraded Gray Television (NYSE: GTN) from a Market Perform rating to an Outperform rating and lifted its price target from $13 to $15.

Athlon Energy (NYSE: ATHL) paid $973 million in cash for 23,500 acres of property in the northern Midland Basin.

On the downside

UBS downgraded Walter Energy (NYSE: WLT) from a Neutral rating to a Sell rating and cut its price target from $8 to $5.

Intuitive Surgical (Nasdaq: ISRG) warned of lower first quarter revenue.

Barclays cut its price target on Diamond Offshore Drilling (NYSE: DO) yesterday from $64 to $52.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by nearly 9 to 5 on Nasdaq. The broader S&P 500 gained 8 points to 1860. Bitcoin slipped $5.93 or 1.33% to $441.57.

Higher Open On Upbeat Earnings

|

The markets opened higher with the Dow gaining 46 points to 16,302 over upbeat corporate earnings. Nasdaq climbed 24 points to 4137. 

On the upside 

MagneGas (Nasdaq: MNGA) filed a new patent for novel methods of binding MagneGas to existing hydrocarbons.

Constant Contact (Nasdaq: CTCT) reported higher preliminary first quarter revenue and lifted its full year revenue forecast.

Wells Fargo upgraded Sinclair Broadcast Group (Nasdaq: SBGI) from a Market Perform rating to an Outperform rating.

On the downside

Ashford Hospitality Trust (NYSE: AHT) priced its public offering of 7.5 million common shares at the discounted price of $10.70 per share.

UBS downgraded Alpha Natural Resources (NYSE: ANR) from a Neutral rating to a Sell rating and lowered its price target from $5 to $3.

UBS downgraded Arch Coal (NYSE: ACI) from a Neutral rating to a Sell rating and cut its price target from $5 to $3.

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 rose 5 points to 1857. Bitcoin slipped $5.98 or 1.34% to $441.52.

The markets closed modestly higher with the Dow adding 10 points to 16,256 as February job openings jumped. Nasdaq climbed 33 points to 4112. 

On the upside 

Chartered Financial analyst Michael Maggi initiated coverage of Seabridge Gold (NYSE: SA) with a Buy rating.

Carolina Breast Imaging Specialists implemented RadNet (Nasdaq: RDNT) subsidiary eRad's webcentric radiology image and data management solution.

Bargain hunters lifted shares of Qihoo 360 Technology (NYSE: QIHU) .

On the downside

Shares of Lands' End (Nasdaq: LE) extended its losses on its second trading.

The Rosen Law Firm began an investigation into Kingold Jewelry (Nasdaq: KGJI) for possibly providing misleading information to investors.

Canaccord Genuity and Stifel both initiated coverage of Castlight Health (NYSE: CSLT) with Buy ratings but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 rose 6 points to 1851. Bitcoin eased $1.26 or 0.28% to $447.00.

A surge in February job openings to a six year high lifted the markets during the midday with the Dow rising 16 points to 16,261. Nasdaq gained 30 points to 4109. 

On the upside 

China Ming Yang Wind Power (NYSE: MY) fell to a loss for the fourth quarter but China is expected to increase wind power capacity.

Credit Suisse upgraded Vipshop Holdings (NYSE: VIPS) from a Neutral rating to an Outperform rating.

Tiger Global Management increased its stake in 58.com (NYSE: WUBA) to 6.5%.

On the downside

Rovi (Nasdaq: ROVI) lost its appeal to overturn a lower court's ruling that Amazon (Nasdaq: AMZN) did not infringe on two Rovi patents.

InterCloud (Nasdaq: ICLD) widened fourth quarter losses.

Ohr Pharmaceutical (Nasdaq: OHRP) announced a registered direct offering of 1.8 million common shares at the discounted price of $10 per share.

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by 7 to 3 on Nasdaq. The broader S&P 500 rose 5 points to 1850. Bitcoin added $3.17 or 0.71% to $451.43.

Mixed Open Ahead Of Earnings

|

The markets opened mixed with the Dow losing 25 points to 16,220. Nasdaq rose 6 points to 4086. 

On the upside 

Alkermes (Nasdaq: ALKS) reported positive results from a late stage clinical trial of its schizophrenia treatment aripiprazole lauroxil and will submit the drug to the Food and Drug Administration for approval in the third quarter.

Bloomberg reported that Ctrip.com (Nasdaq: CTRP) engaged in discussions for a possible merger with Baidu's (Nasdaq: BIDU) Qunar.

Chinese authorities approved the sale of Nokia's (NYSE: NOK) mobile phone business to Microsoft (Nasdaq: MSFT).

On the downside

Nordic American Tankers (NYSE: NAT) increased its public offering to 12 million common shares and priced the offering at the discounted price of $8.62 per share.

Gigamon (NYSE: GIMO) reported lower preliminary first quarter revenue prompting a downgrade.

Spectranetics (Nasdaq: SPNC) warned of wider losses for the first quarter.

In the broad market, declining issues were on par with advancers on the NYSE while advancers outpaced decliners by more than 9 to 7 on Nasdaq. The broader S&P 500 eased a fraction to 1844. Bitcoin edged up $1.99 or 0.44% to $450.24.

Earnings Concerns Sink Stocks

|

Fears that corporate earnings would disappoint sent the markets tumbling to a sharply lower close with the Dow collapsing 166 points to 16,245. Nasdaq plunged 47 points to 4079. 

On the upside 

Pixelworks (Nasdaq: PXLW) appointed former Apple (Nasdaq: AAPL) executive David Tupman to its board.

The Memoranda of Understanding between the Office of Thrift Supervision and TFS Financial (Nasdaq: TFSL) was lifted and the company announced a stock repurchase program to buy back up to 5 million shares of common stock.

Shares of Banco Bradesco (NYSE: BBD) rose as the Brazilian government and banks were close to finalizing a loan for electricity distributors.

On the downside

Puma Biotechnology (NYSE: PBYI) reported disappointing results from a Phase II study of its breast cancer treatment PB272.

Sterne Agee analyst Vijay Rakesh said that Micron Technology (Nasdaq: MU) would gain market share with strong product cycles but the stock price fell.

The Wall Street Journal reported that Yahoo (Nasdaq: YHOO) was seeking to enter the original programming sphere with half-hour comedies spanning ten-episode seasons.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by more than 7 to 2 on Nasdaq. The broader S&P 500 plunged 20 points to 1845. Bitcoin lost $11.82 or 2.56% to $449.07.

Concerns of a tepid earnings season sent the markets tumbling during the midday with the Dow plunging 117 points to 16,295. Nasdaq plummeted 46 points to 4081. 

On the upside 

Idenix (Nasdaq: IDIX) reported continued progress of its nucleotide prodrug development program to treat hepatitis C infection.

Agios Pharmaceuticals (Nasdaq: AGIO) reported promising clinical data of its AG-221 IDH2 mutation inhibitor.

Bargain hunters lifted shares of Petroleo Brasileiro Petrobas (NYSE: PBR).

On the downside

Sears Holdings (Nasdaq: SHLD) completed the separation of Lands' End.

Shares of GTX (Nasdaq: GTXI) extended its losses from Friday when it announced the departure of chief executive officer and co-founder Mitchell S Steiner.

Rite Aid (NYSE: RAD) named David Abelman to the position of senior vice president of brand development and innovation but the stock price fell.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 tumbled 15 points to 1849. Bitcoin lost $18.70 or 4.06% to $442.19.

The markets opened lower with the Dow falling 44 points to 16,367 as earnings season begins tomorrow. Nasdaq lost 6 points to 4121. 

On the upside 

GTCR Valor will take Vocus (Nasdaq: VOCS) private in a deal valued at approximately $446.5 million.

Questcor Pharmaceuticals (Nasdaq: QCOR) will be acquired by Mallinckrodt for a premium of approximately $5.6 billion in cash and stock.

Peregrine (Nasdaq: PPHM) reported that administering its immunotherapy agent bavituximab with stereotatic body radiation therapy improved survival in lung cancer patients by 100%.

On the downside

The Food and Drug Administration extended the Prescription Drug User Fee Act date for MannKind's (Nasdaq: MNKD) AFREZZA by three months.

Investors locked in profits on Genco Shipping & Trading (NYSE: GNK).

World Wrestling Entertainment (NYSE: WWE) reported that its WWE Network digital subscription service has grown to 667,287 subscribers but concerns arose that Pay Per View revenue would drop.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 lost 3 points to 1861. Bitcoin slipped $5.70 or 1.24% to $455.19.

The markets retreated to close sharply lower with the Dow plummeting 159 points to 16,412 despite positive jobs growth as investors locked in profits. Nasdaq collapsed 110 points to 4127. 

On the upside 

Synnex (NYSE: SNX) reported higher first quarter earnings and revenue that surpassed analyst expectations and forecast current quarter results ahead of estimates.

Bargain hunters snapped up shares of Exact Sciences (Nasdaq: EXAS).

Shares of Cemex (NYSE: CX) rose after Bloomberg reported that rival cement makers Holcim and Lafarge were exploring a possible merger.

On the downside

Canaccord raised its price target on Novadaq Technologies (Nasdaq: NVDQ) from $23 to $26 but the stock price fell.

Investors locked in profits on AthenaHealth (Nasdaq: ATHN).

Retrophin (Nasdaq: RTRX) changed its independent accounting firm from Marcum to BDO.

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by more than 5 to 1 on Nasdaq. The broader S&P 500 plunged 23 points to 1865. Bitcoin edged up $0.81 or 0.18% to $446.56.

The markets turned negative during the midday with the Dow losing 24 points to 16,548 over concerns that the Federal Reserve would accelerate its tapering program. Nasdaq plunged 76 points to 4161. 

On the upside 

Shares of IMS Health Holdings (NYSE: IMS) soared in its market debut.

GrubHub (NYSE: GRUB) stock surged on its first trading day.

Shares of Five9 (Nasdaq: FIVN) climbed in its debut.

On the downside

Profit taking continued to weigh down Idera Pharmaceuticals (Nasdaq: IDRA).

CytRx (Nasdaq: CYTR) extended its losses.

Micron Technology (Nasdaq: MU) swung to a profit for the second quarter but the company warned that average selling prices would drop in the current quarter.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE while decliners edged out advancers by nearly 5 to 2 on Nasdaq. The broader S&P 500 lost 8 points to 1880. Bitcoin eased $1.81 or 0.40% to $443.94.

Higher Open Over Job Growth

|

Strong jobs growth in March lifted the markets to a higher open with the Dow rising 34 points to 16,606. Nasdaq edged up a point to 4239. 

On the upside 

China Finance Online (Nasdaq: JRJC) swung to a profit for the fourth quarter as revenue surged.

Genco Shipping & Trading (NYSE: GNK) reached a restructuring agreement with certain lenders.

J.P. Morgan upgraded Andarko Petroleum (NYSE: APC) to an Overweight rating.

On the downside

Halozyme Therapeutics (Nasdaq: HALO) temporarily halted enrollment in a Phase 2 clinical trial of its pancreatic cancer treatment PEGPH20.

Western Asset Mortgage Capital (NYSE: WMC) priced its public offering of 13 million common shares at the discounted price of $14.85 per share.

Ocean Power Technologies (Nasdaq: OPTT) priced its offering of 3.8 million common shares at the discounted price of $3.10 per share.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 rose 6 points to 1894. Bitcoin eased $1.22 or 0.27% to $444.53.

The markets closed lower with the Dow easing a fraction to 16,572 as jobless claims rose more than expected. Nasdaq dropped 38 points to 4237. 

On the upside 

Andarko Petroleum (NYSE: APC) will pay approximately $5.15 billion to settle environmental pollution claims.

Kellogg (NYSE: K) partnered with baseball Hall of Famer Cal Ripken Jr. to celebrate fans who "Never Miss a Game."

Bargain hunters lifted shares of Prana Biotechnology (Nasdaq: PRAN).

On the downside

SGOCO Group (Nasdaq: SGOC) reported sharply lower preliminary fourth quarter earnings and revenue.

NSS Labs rated FireEye (Nasdaq: FEYE) "Below Average" for its breach detection system.

Exact Sciences (Nasdaq: EXAS) will offer $125 million worth of common stock through a public offering.

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by 7 to 3 on Nasdaq. The broader S&P 500 slipped 2 points to 1888. Bitcoin added $6.93 or 1.57% to $448.05.

A greater than expected increase in jobless claims weighed the markets down during the midday with the Dow losing 19 points to 16,553. Nasdaq tumbled 41 points to 4234. 

On the upside 

Shares of Tarena International (Nasdaq: TEDU) climbed on its first trading day.

Catalyst Pharmaceutical Partners (Nasdaq: CPRX) priced its public offering of 11.325 million common shares at the discounted price of $2.21 per share but the stock price rose.

Amyris (Nasdaq: AMRS) entered a research and development collaboration with BASF.

On the downside

Venaxis (Nasdaq: APPY) priced its public offering of 8.335 million common shares at the discounted price of $2.40 per share.

Pacific Ethanol (Nasdaq: PEIX) priced its public offering of 1.75 million common shares at the discounted price of $16.00 per share.

Celldex Therapeutics (Nasdaq: CLDX) will present data from preclinical studies of the antibody-drug conjugate CDX-014 at the American Association of Cancer Research Annual Meeting on Monday, April 7, 2014.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 slipped 4 points to 1886. Bitcoin added $7.63 or 1.73% to $448.75.

The markets opened mixed with the Dow rising 15 points to 16,588 while Nasdaq slipped 6 points to 4269 as first time applications for unemployment benefits rose more than expected. 

On the upside 

Response Genetics (Nasdaq: RGDX) signed contracts with six new health plans across ten states.

CytRx (Nasdaq: CYTR) reported positive preclinical results from an in vivo study of aldoxorubicin for treating relapsed glioblastoma.

MagneGas (Nasdaq: MNGA) announced a that Sidney Lee Welding Supply will distribute MagneGas fuel throughout Georgia.

On the downside

Liquidity Services (Nasdaq: LQDT) withdrew from the live auction bidding for the rolling stock surplus contract with the Defense Logistics Agency.

Liberty Media will reduce its 17% stake in Barnes & Noble (NYSE: BKS) to 10% and lose two preferred stock director board seats.

BG Medicine (Nasdaq: BGMD) priced its public offering of 6.452 million common shares at the discounted price of $1.55 per share.

In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 held steady at 1890. Bitcoin lost $12.39 or 2.81% to $428.73.

A gain in factory orders and jobs lifted the markets to a higher close with the Dow gaining 40 points to 16,573. Nasdaq added 8 points to 4276. 

On the upside 

Autobytel (Nasdaq: ABTL) lifted its first quarter revenue outlook.

Belgium bus manufacturer Van Hool delivered four buses powered by Ballard Power's (Nasdaq: BLDP) fuel cells.

Celgene (Nasdaq: CELG) will increase its stake in Acceleron Pharma (Nasdaq: XLRN) to 14.8%.

On the downside

Investors locked in profits on Amyris (Nasdaq: AMRS).

Genco Shipping (NYSE: GNK) must restructure its debt by April 4 to avoid bankruptcy.

Ellie Mae (Nasdaq: ELLI) experienced system outages due to unusually high demand for services.

In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 rose 5 points to 1890. Bitcoin slipped $2.11 or 0.48% to $439.01.

Strong growth in factory orders lifted the markets during the midday with the Dow adding 22 points to 16,554. Nasdaq rose 5 points to 4273. 

On the upside 

Shares of Rubicon Project (NYSE: RUBI) soared in its market debut.

Alliance Fiber Optics Products (Nasdaq: AFOP) reported preliminary first quarter revenue that more than doubled to top expectations.

China Digital TV Holding (NYSE: STV) declared a special cash dividend of $0.50 per common share payable on May 9, 2014 to shareholder of record April 14, 2014.

On the downside

Shares of Identive Group (Nasdaq: INVE) continued falling.

GlaxoSmithKline (NYSE: GSK) halted a Phase 3 study of its non-small cell lung cancer treatment that contains Agenus' (Nasdaq: AGEN) QS-21 Stimulon®.

ARIAD Pharmaceuticals (Nasdaq: ARIA) appointed Hugh M. Cole to the position of senior vice president and chief business officer.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 5 points to 1890. Bitcoin fell $32.42 or 6.66% to $454.36.

Higher Open On Jobs Data

|

The nation's private employers hired 191,000 workers in March to lift the markets to a higher open with the Dow gaining 20 points to 16,552. Nasdaq added 7 points to 4275. 

On the upside 

A Food and Drug Administration advisory panel recommended approval for MannKind's (Nasdaq: MNKD) inhalable insulin product AFREZZA.

Envivio (Nasdaq: ENVI) will power premium live HD sports channels on Apple TV (Nasdaq: AAPL) for a European Tier 1 service provider.

The Centers for Medicare & Medicaid Services increased the reimbursement amount for BRCA1 and BRCA2 sequencing sending shares of Myriad Genetics (Nasdaq: MYGN) soaring.

On the downside

Apollo Education Group (Nasdaq: APOL) reported higher second quarter earnings but revenue fell short of analyst expectations.

Robert W. Baird said that Liquidity Services' (Nasdaq: LQDT) winning bid for a Defense Logistics Agency contract was too high.

Investors locked in profits on Higherpower International (Nasdaq: HPJ).

In the broad market, advancing issues were on par with decliners on both the NYSE and on Nasdaq. The broader S&P 500 added 3 points to 1888. Bitcoin fell $21.83 or 4.49% to $464.94.

An uptick in the nation's manufacturing activity boosted the markets to a sharply higher close with the Dow climbing 74 points to 16,532. Nasdaq leaped 69 points to 4268. 

On the upside 

Providence Service (Nasdaq: PRSC) will purchase Ingeus for approximately $58 million in cash.

The United States Maritime Administration reported that Amyris' (Nasdaq: AMRS) Renewable Diesel fuel reduced emissions without significant impact on engine performance.

Bargain hunters lifted shares of Zulily (Nasdaq: ZU).

On the downside

Investors locked in profits on Energous (Nasdaq: WATT).

JGWPT Holdings (NYSE: JGW) fell to a loss for the fourth quarter.

McDermott International (Nasdaq: MDR) will offer 10 million tangible equity units.

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 climbed 13 points to close at a record 1885. Bitcoin gained $27.54 or 6.06% to $482.22.

The markets traded higher during the midday with the Dow rising 42 points to 16,500 as the nation's manufacturing activity edged up in March. Nasdaq soared 41 points to 4240. 

On the upside 

JP Morgan upgraded Rubicon Technology (Nasdaq: RBCN) from a Neutral rating to an Overweight rating and lifted its price target from $12 to $14.

Shares of 58.com (NYSE: WUBA) extended its gains.

Investor's Business Daily listed Pacific Ethanol (Nasdaq: PEIX) as the top alternative energy stock that beat analyst earnings expectations by the widest margin.

On the downside

Investors locked in profits on BioFuel Energy (Nasdaq: BIOF).

YOU On Demand (Nasdaq: YOD) widened losses for the 2013 year.

Shares of Prana Biotechnology (Nasdaq: PRAN) continued falling.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 rose 6 points to 1878. Bitcoin gained $32.55 or 7.18% to $486.11.

The markets opened higher with the Dow climbing 92 points to 16,549 after Federal Reserve chair Janet Yellen said yesterday that interest rates would remain low for some time. Nasdaq leaped 49 points to 4248. 

On the upside 

The Food and Drug Administration approved Intuitive Surgical's (Nasdaq: ISRG) da Vinci Xi Surgical System and will introduce the system in the U. S.

Arrowhead Research (Nasdaq: ARWR) completed enrollment of the first cohort in a Phase 2c trial of its chronic hepatitis B treatment ARC-520.

Hilltop Holdings will acquire SWS Group (NYSE: SWS).

On the downside


A district court judge found that Hospira did not infringe on two The Medicines Co. (Nasdaq: MDCO) patents.

Arotech (Nasdaq: ARTX) widened fourth quarter losses as revenue fell. The company acquired UEC Electronics.

Clean Diesel Technologies (Nasdaq: CDTI) will offer more than 2 million shares of common stock at the discounted price of $3.40 per share.

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 gained 10 points to 1883. Bitcoin rose $24.95 or 5.49% to $479.62.

About this Archive

This page is an archive of entries from April 2014 listed from newest to oldest.

March 2014 is the previous archive.

May 2014 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12